Home » Topics » BioWorld Science

BioWorld Science
RSS

OnKure begins new phase I trial of OKI-179 in solid tumors

May 27, 2019

Genmab initiates phase I/IIa safety study of GEN-1046 in malignant solid tumors

May 27, 2019

Phase III study of Lyrica in PGTC seizures fails to meet primary endpoint

May 27, 2019

PCI Biotech begins pivotal RELEASE study of fimaChem in inoperable bile duct cancer

May 27, 2019

Sensorion signs hearing loss research partnership framework agreement with Institut Pasteur

May 27, 2019

Alpine Immune Sciences divulges new fusion proteins

May 27, 2019

Nanjing CART Medical Technologies discloses CAR T cells for hematologic cancer

May 27, 2019

Zealand Pharma describes amylin and/or calcitonin receptor agonists

May 27, 2019

FDA approves Piqray for HR+/HER2-, PIK3CA-mutated advanced breast cancer

May 27, 2019

ORIC Pharmaceuticals presents CD73 inhibitors

May 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...